TB500: Thymosin B4 Acetate 2 mg
Preserved as the source name pending sequence and form resolution.
CAD $35.00 / vial
Vial amount
The specifics, clearly listed.
Product details
Product reference: MRD-0153 Listed amount per vial: 2 mg Sales unit: 1 vial
Read the research in context.
Preserved as the source name pending sequence and form resolution.
- Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential — source
Candidate-molecule or reference-product background; not verification of this supplied product.
What this doesn’t establish: Source name combines TB500 with Thymosin B4 Acetate; these labels cannot be assumed to denote the same molecule. Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.
Product documents
No verified report is available here for this item. Ask about documentation for TB500: Thymosin B4 Acetate, product reference MRD-0153.
Before you decide.
Separate research about the compound from evidence about the supplied product.
Which vial amount is shown?
This listing shows 2 mg per vial.
Does the study verify this vial?
No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.
What should I check in a report?
Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.
What information should I request?
Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.